| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $44.7M | +26.0% |
| SG&A Expense | $12.2M | +3.4% |
| Operating Income | -$64.6M | -36.7% |
| Net Income | -$65.2M | -221.2% |
| EPS (Basic) | -$124.97 | -183.3% |
| EPS (Diluted) | -$124.97 | -183.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.9M | -46.5% |
| Short-term Investments | $4.8M | -87.3% |
| Current Assets | $17.7M | -71.8% |
| Total Assets | $20.7M | -69.0% |
| Current Liabilities | $20.8M | +71.2% |
| Total Liabilities | $32.5M | +87.1% |
| Stockholders' Equity | -$11.9M | -124.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.0M | -11.8% |
| Capital Expenditures | $62K | — |
| Investing Cash Flow | $32.1M | +376.3% |
| Financing Cash Flow | $6.1M | -88.6% |
| Free Cash Flow | -$46.0M | — |